NDC 31722-0506-60
LAMIVUDINE and ZIDOVUDINE 150 mg/1, 300 mg/1 TABLET, FILM COATED
Available — 2-Day Shipping
NDC
31722-0506-60
Generic Name
LAMIVUDINE and ZIDOVUDINE
Brand Name
LAMIVUDINE and ZIDOVUDINE
Strength
150 mg/1, 300 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Package Size
—
Labeler
Camber Pharmaceuticals, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All LAMIVUDINE and ZIDOVUDINE Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 31722-0506-60 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).